| Product Code: ETC8834540 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The angioedema market in the Philippines is small but developing, with growing awareness of hereditary and acquired forms. The demand for effective treatments like C1 esterase inhibitors and antihistamines is rising, particularly in urban hospitals. Delayed diagnosis and limited access to advanced therapies restrict the markets growth potential. Educational campaigns and improved genetic testing may help expand this market in the future.
The angioedema market in the Philippines is gradually expanding with increased recognition of hereditary and acquired forms. Advances in diagnostics and the availability of targeted therapies, such as C1 esterase inhibitors and bradykinin receptor antagonists, improve patient care. However, challenges related to awareness and access to expensive treatments persist.
The agricultural microbial market is challenged by lack of farmer awareness regarding the benefits of microbial products and concerns about product efficacy under local conditions. Regulatory approvals can be cumbersome, delaying product availability. Similarly, agricultural mulch films face environmental concerns and disposal challenges, limiting their acceptance despite benefits in crop yield.
The angioedema treatment market in the Philippines is expanding as better diagnostic capabilities and awareness improve disease recognition. Investment prospects lie in developing and distributing novel biologic therapies and expanding access to acute and prophylactic treatments. Establishing patient support and education programs alongside healthcare provider training can further enhance treatment uptake in this rare disease segment.
Management of angioedema is supported under immunology and rare disease programs. The government promotes access to emergency treatment, specialized drugs, and long-term management protocols. Policies focus on patient education and integration of angioedema care in allergy clinics.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Philippines Angioedema Market Overview |
3.1 Philippines Country Macro Economic Indicators |
3.2 Philippines Angioedema Market Revenues & Volume, 2021 & 2031F |
3.3 Philippines Angioedema Market - Industry Life Cycle |
3.4 Philippines Angioedema Market - Porter's Five Forces |
3.5 Philippines Angioedema Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.6 Philippines Angioedema Market Revenues & Volume Share, By Route Of Administration, 2021 & 2031F |
3.7 Philippines Angioedema Market Revenues & Volume Share, By Disease Indication, 2021 & 2031F |
3.8 Philippines Angioedema Market Revenues & Volume Share, By Therapy, 2021 & 2031F |
3.9 Philippines Angioedema Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
3.10 Philippines Angioedema Market Revenues & Volume Share, By End-User, 2021 & 2031F |
4 Philippines Angioedema Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness and diagnosis of angioedema in the Philippines. |
4.2.2 Growing healthcare expenditure and investments in healthcare infrastructure. |
4.2.3 Rising prevalence of allergic conditions leading to an increase in angioedema cases. |
4.3 Market Restraints |
4.3.1 Limited access to specialized treatment centers for angioedema. |
4.3.2 High costs associated with long-term management and treatment of angioedema. |
4.3.3 Lack of trained healthcare professionals in the field of angioedema management. |
5 Philippines Angioedema Market Trends |
6 Philippines Angioedema Market, By Types |
6.1 Philippines Angioedema Market, By Product Type |
6.1.1 Overview and Analysis |
6.1.2 Philippines Angioedema Market Revenues & Volume, By Product Type, 2021- 2031F |
6.1.3 Philippines Angioedema Market Revenues & Volume, By Solid Dosage Form, 2021- 2031F |
6.1.4 Philippines Angioedema Market Revenues & Volume, By Liquid Dosage Form, 2021- 2031F |
6.2 Philippines Angioedema Market, By Route Of Administration |
6.2.1 Overview and Analysis |
6.2.2 Philippines Angioedema Market Revenues & Volume, By Parenteral Route, 2021- 2031F |
6.2.3 Philippines Angioedema Market Revenues & Volume, By Subcutaneous, 2021- 2031F |
6.2.4 Philippines Angioedema Market Revenues & Volume, By Intravenous, 2021- 2031F |
6.2.5 Philippines Angioedema Market Revenues & Volume, By Oral Route, 2021- 2031F |
6.3 Philippines Angioedema Market, By Disease Indication |
6.3.1 Overview and Analysis |
6.3.2 Philippines Angioedema Market Revenues & Volume, By Acquired Angioedema, 2021- 2031F |
6.3.3 Philippines Angioedema Market Revenues & Volume, By Idiopathic Angioedema, 2021- 2031F |
6.3.4 Philippines Angioedema Market Revenues & Volume, By Allergic Angioedema, 2021- 2031F |
6.3.5 Philippines Angioedema Market Revenues & Volume, By Drug-Induced Angioedema, 2021- 2031F |
6.3.6 Philippines Angioedema Market Revenues & Volume, By Hereditary Angioedema, 2021- 2031F |
6.4 Philippines Angioedema Market, By Therapy |
6.4.1 Overview and Analysis |
6.4.2 Philippines Angioedema Market Revenues & Volume, By Idiopathic Angioedema Drug Class, 2021- 2031F |
6.4.3 Philippines Angioedema Market Revenues & Volume, By Antihistamine, 2021- 2031F |
6.4.4 Philippines Angioedema Market Revenues & Volume, By Corticosteroids, 2021- 2031F |
6.4.5 Philippines Angioedema Market Revenues & Volume, By Glucocorticoids, 2021- 2031F |
6.4.6 Philippines Angioedema Market Revenues & Volume, By Adrenaline Injection, 2021- 2031F |
6.4.7 Philippines Angioedema Market Revenues & Volume, By Hereditary Angioedema Drug Class, 2021- 2031F |
6.4.8 Philippines Angioedema Market Revenues & Volume, By Selective Bradykinin B2 Receptor Antagonist, 2021- 2031F |
6.4.9 Philippines Angioedema Market Revenues & Volume, By Selective Bradykinin B2 Receptor Antagonist, 2021- 2031F |
6.5 Philippines Angioedema Market, By Distribution Channel |
6.5.1 Overview and Analysis |
6.5.2 Philippines Angioedema Market Revenues & Volume, By Hospital Pharmacies, 2021- 2031F |
6.5.3 Philippines Angioedema Market Revenues & Volume, By Retail Pharmacies, 2021- 2031F |
6.5.4 Philippines Angioedema Market Revenues & Volume, By Online Pharmacies, 2021- 2031F |
6.6 Philippines Angioedema Market, By End-User |
6.6.1 Overview and Analysis |
6.6.2 Philippines Angioedema Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.6.3 Philippines Angioedema Market Revenues & Volume, By Homecare Settings, 2021- 2031F |
6.6.4 Philippines Angioedema Market Revenues & Volume, By Clinics, 2021- 2031F |
7 Philippines Angioedema Market Import-Export Trade Statistics |
7.1 Philippines Angioedema Market Export to Major Countries |
7.2 Philippines Angioedema Market Imports from Major Countries |
8 Philippines Angioedema Market Key Performance Indicators |
8.1 Number of patients diagnosed with angioedema annually. |
8.2 Percentage increase in healthcare expenditure towards angioedema management. |
8.3 Adoption rate of new treatments and therapies for angioedema in the Philippines. |
8.4 Number of specialized treatment centers for angioedema established in the country. |
8.5 Percentage of healthcare professionals trained in angioedema diagnosis and management. |
9 Philippines Angioedema Market - Opportunity Assessment |
9.1 Philippines Angioedema Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.2 Philippines Angioedema Market Opportunity Assessment, By Route Of Administration, 2021 & 2031F |
9.3 Philippines Angioedema Market Opportunity Assessment, By Disease Indication, 2021 & 2031F |
9.4 Philippines Angioedema Market Opportunity Assessment, By Therapy, 2021 & 2031F |
9.5 Philippines Angioedema Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
9.6 Philippines Angioedema Market Opportunity Assessment, By End-User, 2021 & 2031F |
10 Philippines Angioedema Market - Competitive Landscape |
10.1 Philippines Angioedema Market Revenue Share, By Companies, 2024 |
10.2 Philippines Angioedema Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here